© 2021 MJH Life Sciences and Consultant Live. All rights reserved.
June 17, 2021
Gerald Sacks, MD, and Fariborz Rezai, MD, FCCP, FCCM, share their personal experience in approaching and openly communicating the management of opioid-induced constipation with patients.
The role of lifestyle modifications and over-the-counter products to prevent opioid-induced constipation in patients is discussed.
June 10, 2021
Gerald Sacks, MD, and Fariborz Rezai, MD, FCCP FCCM, share their approach to selecting PAMORAs in clinical practice for the optimal management of opioid-induced constipation.
A discussion on the use of oral methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic non-cancer pain and the implications for clinical practice.